1. Home
  2. RAPT vs EVN Comparison

RAPT vs EVN Comparison

Compare RAPT & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • EVN
  • Stock Information
  • Founded
  • RAPT 2015
  • EVN 1998
  • Country
  • RAPT United States
  • EVN United States
  • Employees
  • RAPT N/A
  • EVN N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • EVN Investment Bankers/Brokers/Service
  • Sector
  • RAPT Health Care
  • EVN Finance
  • Exchange
  • RAPT Nasdaq
  • EVN Nasdaq
  • Market Cap
  • RAPT 498.4M
  • EVN 444.3M
  • IPO Year
  • RAPT 2019
  • EVN N/A
  • Fundamental
  • Price
  • RAPT $28.83
  • EVN $11.06
  • Analyst Decision
  • RAPT Strong Buy
  • EVN
  • Analyst Count
  • RAPT 9
  • EVN 0
  • Target Price
  • RAPT $57.00
  • EVN N/A
  • AVG Volume (30 Days)
  • RAPT 778.5K
  • EVN 101.2K
  • Earning Date
  • RAPT 11-06-2025
  • EVN 01-01-0001
  • Dividend Yield
  • RAPT N/A
  • EVN 4.78%
  • EPS Growth
  • RAPT N/A
  • EVN N/A
  • EPS
  • RAPT N/A
  • EVN 0.34
  • Revenue
  • RAPT N/A
  • EVN N/A
  • Revenue This Year
  • RAPT N/A
  • EVN N/A
  • Revenue Next Year
  • RAPT N/A
  • EVN N/A
  • P/E Ratio
  • RAPT N/A
  • EVN $29.94
  • Revenue Growth
  • RAPT N/A
  • EVN N/A
  • 52 Week Low
  • RAPT $5.67
  • EVN $8.64
  • 52 Week High
  • RAPT $42.39
  • EVN $10.45
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 53.26
  • EVN 50.30
  • Support Level
  • RAPT $27.76
  • EVN $11.03
  • Resistance Level
  • RAPT $29.90
  • EVN $11.19
  • Average True Range (ATR)
  • RAPT 1.66
  • EVN 0.13
  • MACD
  • RAPT -0.46
  • EVN 0.00
  • Stochastic Oscillator
  • RAPT 41.72
  • EVN 60.02

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About EVN Eaton Vance Municipal Income Trust

Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.

Share on Social Networks: